Rosette-Disrupting Effect of an Anti-Plasmodial Compound for the Potential Treatment of Plasmodium falciparum Malaria Complications

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ch'ng, Jun Hong ^a,b   Moll, Kirsten ^a   Quintana, Maria Del Pilar ^a,c   Chan, Sherwin Chun Leung ^a   Masters, Ellen ^d   Moles, Ernest ^e,f,g   Liu, Jianping ^a   Eriksson, Anders B ^a   Wahlgren, Mats ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSIDAD DEL ROSARIO   (Colombia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL; CEREBRAL MALARIA; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECT; DRUG RESISTANCE; ERYTHROCYTE; HIGH THROUGHPUT SCREENING; HUMAN; MALARIA FALCIPARUM; MICROCIRCULATION; MICROVASCULATURE; PARASITE LOAD; PARASITOLOGY; PATHOLOGY; PLASMODIUM FALCIPARUM; PROCEDURES;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG DISCOVERY; DRUG RESISTANCE; ERYTHROCYTES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MICROCIRCULATION; MICROVESSELS; PARASITE LOAD; PLASMODIUM FALCIPARUM; PYRIDINES;

EID: 84978381260     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29317     Document Type: Article

References (34)

1. Birbeck, G. L. et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. The Lancet. Neurology 9, 1173-1181, doi: 10.1016/S1474-4422(10)70270-2 (2010).
2. Idro, R., Marsh, K., John, C. C. & Newton, C. R. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatric research 68, 267-274, doi: 10.1203/00006450-201011001-0052410.1203/PDR.0b013e3181eee738 (2010).
3. Kaul, D. K., Roth, E. F. Jr., Nagel, R. L., Howard, R. J. & Handunnetti, S. M. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 78, 812-819 (1991).
4. Doumbo, O. K. et al. High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children. Am J Trop Med Hyg 81, 987-993, doi: 10.4269/ajtmh.2009.09-0406 (2009).
5. Smith, J. D., Rowe, J. A., Higgins, M. K. & Lavstsen, T. Malaria's deadly grip: cytoadhesion of Plasmodium falciparum-infected erythrocytes. Cell Microbiol 15, 1976-1983, doi: 10.1111/cmi.12183 (2013).
6. Goel, S. et al. RIFINs are adhesins implicated in severe Plasmodium falciparum malaria. Nat Med 21, 314-317, doi: 10.1038/ nm.3812 (2015).
7. Niang, M. et al. STEVOR is a Plasmodium falciparum erythrocyte binding protein that mediates merozoite invasion and rosetting. Cell host & microbe 16, 81-93, doi: 10.1016/j.chom.2014.06.004 (2014).
8. Lee, W. C. et al. Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes. Blood 123, e100-109, doi: 10.1182/blood-2013-12-541698 (2014).
9. Lowe, B. S., Mosobo, M. & Bull, P. C. All four species of human malaria parasites form rosettes. Trans R Soc Trop Med Hyg 92, 526 (1998).
10. Malleret, B. et al. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci Rep 1, 118, doi: 10.1038/srep00118 (2011).
11. Albrecht, L. et al. B-Cell Epitopes in NTS-DBL1alpha of PfEMP1 Recognized by Human Antibodies in Rosetting Plasmodium falciparum. PLoS One 9, e113248, doi: 10.1371/journal.pone.0113248 (2014).
12. Barragan, A., Spillmann, D., Kremsner, P. G., Wahlgren, M. & Carlson, J. Plasmodium falciparum: molecular background to strainspecific rosette disruption by glycosaminoglycans and sulfated glycoconjugates. Exp Parasitol 91, 133-143, doi: 10.1006/ expr.1998.4349 (1999).
13. Gullingsrud, J. et al. High-throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes. J Infect Dis 211, 1134-1143, doi: 10.1093/infdis/jiu589 (2015).
14. Carlson, J. et al. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336, 1457-1460 (1990).
15. Carlson, J., Nash, G. B., Gabutti, V., al-Yaman, F. & Wahlgren, M. Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood 84, 3909-3914 (1994).
16. Rowe, A., Obeiro, J., Newbold, C. I. & Marsh, K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 63, 2323-2326 (1995).
17. Moll, K., Kaneko, A., Scherf, A. & Wahlgren, M. Methods in Malaria Research (6th Edition). (EviMalaR, Glasgow, UK & MR4/ ATCC, Manassas, VA, USA, 2013, 2014).
18. Wersto, R. P. et al. Doublet discrimination in DNA cell-cycle analysis. Cytometry 46, 296-306 (2001).
19. Houtz, B., Trotter, J. & Sasaki, D. BD FACService TECHNOTES Special Sorting Issue. (2004) Available at: http://www.bdbiosciences. com/documents/BD-Research-Sorting-TechBulletin.pdf. (Accessed: 9 May 2016).
20. Hughes, O. R., Stewart, R., Dimmick, I. & Jones, E. A. A critical appraisal of factors affecting the accuracy of results obtained when using flow cytometry in stem cell investigations: where do you put your gates? Cytometry. Part A : the journal of the International Society for Analytical Cytology 75, 803-810, doi: 10.1002/cyto.a.20764 (2009).
21. Pasvol, G. The treatment of complicated and severe malaria. Br Med Bull 75-76, 29-47, doi: 10.1093/bmb/ldh059 (2005).
22. Hughes, K. R., Biagini, G. A. & Craig, A. G. Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment. Mol Biochem Parasitol 169, 71-78, doi: 10.1016/j.molbiopara.2009.09.007 (2010).
23. Jaroonvesama, N. Intravascular coagulation in falciparum malaria. Lancet 1, 221-223 (1972).
24. Smitskamp, H. & Wolthuis, F. H. New concepts in treatment of malignant tertian malaria with cerebral involvement. British medical journal 1, 714-716 (1971).
25. Severe and complicated malaria. World Health Organization Malaria Action Programme. Trans R Soc Trop Med Hyg 80 Suppl, 3-50 (1986).
26. Fischer, P. R. & Boone, P. Short report: severe malaria associated with blood group. Am J Trop Med Hyg 58, 122-123 (1998).
27. Fry, A. E. et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Human molecular genetics 17, 567-576, doi: 10.1093/hmg/ddm331 (2008).
28. Beiguelman, B. et al. The association of genetic markers and malaria infection in the Brazilian Western Amazonian region. Mem Inst Oswaldo Cruz 98, 455-460 (2003).
29. Pathirana, S. L. et al. ABO-blood-group types and protection against severe, Plasmodium falciparum malaria. Ann Trop Med Parasitol 99, 119-124, doi: 10.1179/136485905X19946 (2005).
30. Rowe, J. A. et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci USA 104, 17471-17476, doi: 10.1073/pnas.0705390104 (2007).
31. Spillmann, D., Witt, D. & Lindahl, U. Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem 273, 15487-15493 (1998).
32. Spillmann, D., Lookene, A. & Olivecrona, G. Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase. J Biol Chem 281, 23405-23413, doi: 10.1074/jbc.M604702200 (2006).
33. Angeletti, D. et al. Plasmodium falciparum rosetting epitopes converge in the SD3-loop of PfEMP1-DBL1alpha. PLoS One 7, e50758, doi: 10.1371/journal.pone.0050758 (2012).
34. Spangenberg, T. et al. The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One 8, e62906, doi: 10.1371/journal.pone.0062906 (2013).